TGFβ1 was reported to upregulate TG2 in ovarian cancer by upregulating the activity of NFκB [17] and via the ERK and PI3/AKT pathway in diseased pulmonary fibroblast [41]. This evidence concerns the gene TGM2 and ovarian carcinoma.